SUN VALLEY, CA--(Marketwire - October 08, 2010) -
XTend Medical, (PINKSHEETS: XMDC
), a company that specializes in delivering life changing medical technology to healthcare organizations globally, has informed Pink Sheets that our status as an ongoing company with operations has not changed since August of 2007. Pink Sheets had inadvertently set a defaulted status to reflect the wrong type of company and will make the changes to our status immediately. We regret any inconsistency that may have occurred to our shareholders.
About XTend Medical
XTend Medical is a company that specializes in the sales, manufacturing and distribution of the latest in medical devices and telemedicine solutions for the healthcare industry. Their dedication to insuring the products and services offered to healthcare organizations, third-world countries, and physician groups are at the forefront of medical technology. Their recent acquisition of the BioHarp medical device will assist the company in becoming known as a leader in the healthcare sector globally. For further information, please contact them at firstname.lastname@example.org or visit their website at www.bioharpunius.com.
This press release may contain forward-looking statements covered within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements relate to, among other things, plans and timing for the introduction or enhancement of our services and products, statements about future market conditions, supply and demand conditions, and other expectations, intentions and plans contained in this press release that are not historical fact and involve risks and uncertainties. Our expectations regarding future revenues depend upon our ability to develop and supply products and services that we may not produce today and that meet defined specifications. When used in this press release, the words "plan," "expect," "believe," and similar expressions generally identify forward-looking statements. These statements reflect our current expectations. They are subject to a number of risks and uncertainties, including, but not limited to, changes in technology and changes in pervasive markets.